Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV

Central South University · Xiangya Hospital Central South University

PubMed
Indexed incrossrefdoajpubmed

Abstract

Background

The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions.

Methods

Based on recently published literature, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) infection.

Citation impact

480
total citations
FWCI
11.57
Percentile
100%
References
58
Citations per year

Authors

2

Topics & keywords

Keywords
  • Interim
  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Coronavirus disease 2019 (COVID-19)
  • 2019-20 coronavirus outbreak
  • Coronavirus
  • Betacoronavirus
  • Virology
  • Middle East respiratory syndrome coronavirus
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.